Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China flag China · Delayed Price · Currency is CNY
11.71
-0.46 (-3.78%)
Aug 24, 2026, 3:04 PM CST

SHE:300003 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
770.56962.01246.941,2582,2041,719
Depreciation & Amortization
645.34638.8560.04513.56488.47448.74
Other Amortization
78.8883.4696.4290.2279.1672.83
Loss (Gain) From Sale of Assets
-5.84-4.87-11.737.871.69-19.9
Asset Writedown & Restructuring Costs
44.0543.83134.7636.59-2.39
Loss (Gain) From Sale of Investments
-78.95-54.289.2913.4470.91367.54
Provision & Write-off of Bad Debts
46.2438.8750.3626.1324.4520.76
Other Operating Activities
410.3369.67284.62337.04278.83308.15
Change in Accounts Receivable
-312.86-489.63-62.843.22-665.0742.85
Change in Inventory
-137.36-198.73206.28-251.01-386.7-494.73
Change in Accounts Payable
162.06168.11-688.65-982710.12660.39
Operating Cash Flow
1,5131,517734.64990.362,7913,062
Operating Cash Flow Growth
24.83%106.48%-25.82%-64.51%-8.86%46.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-919.34-643.06-658.82-844.67-905.22-984.4
Sale of Property, Plant & Equipment
0.651.6230.038.522.552.09
Cash Acquisitions
---21.82-344.92-3.1-453.01
Divestitures
-13.24-13.954.42-48.08-0.15
Investment in Securities
312.04-352.93-237.88-65.41-648.89129.18
Other Investing Activities
196.57182.473.66-428.320.47533.27
Investing Cash Flow
-235.2-690.74-743.9-1,886-1,599-860.46

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Long-Term Debt Issued
-3,1513,1682,6941,8283,745
Long-Term Debt Repaid
--2,580-2,352-2,320-2,601-4,338
Total Debt Repaid
-3,964-2,580-2,352-2,320-2,601-4,338
Net Debt Issued (Repaid)
363.16571.51815.96373.41-772.86-592.54
Issuance of Common Stock
----1,533-
Repurchase of Common Stock
---177.43-75.24-245.91-109.91
Common Dividends Paid
-841.7-681.55-990.89-768.66-635.65-587.04
Other Financing Activities
-188.8927.68-132.86177.57534.17392.09
Financing Cash Flow
-667.42-82.36-485.22-292.92412.75-897.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
-56.02-16.788.92-20.5921.13-11.31
Net Cash Flow
554.48727.04-485.56-1,2091,6251,293

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
593.78873.8675.82145.691,8852,078
Free Cash Flow Growth
-4.61%1052.51%-47.96%-92.27%-9.25%39.48%
Free Cash Flow Margin
9.38%13.48%1.24%1.83%17.77%19.49%
Free Cash Flow Per Share
0.320.470.040.081.041.15
Levered Free Cash Flow
514.39-131.9736.41-338.091,6031,479
Unlevered Free Cash Flow
683.74-21.57149.53-231.431,7211,622

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
550.02614.84775.28970.56962.96725.21
Change in Working Capital
-397.46-560.65-716.06-1,293-356.6142.15